3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
956
Radiotherapy
847
Cisplatin
757
Gemcitabine
657
Carboplatin
603
Docetaxel
598
Paclitaxel
585
Bevacizumab
581
Fluorouracil
504
Oxaliplatin
458
Rituximab
454
Surveys and Questionnaires
449
Capecitabine
440
Dexamethasone
428
Doxorubicin
424
Etoposide
411
Irinotecan
389
Cytarabine
376
Filgrastim
369
pembrolizumab
330
Leucovorin
305
Nivolumab
297
fludarabine phosphate
294
Melphalan
288
Magnetic Resonance Spectroscopy
281
Peripheral Blood Stem Cell Transplantation
279
Blood Specimen Collection
279
Lenalidomide
277
Methotrexate
276
Cetuximab
270
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
irosustat
×
Clear all
NCT01785992
2015-03-24
IRIS
Imperial College London
Phase 2
Completed
27 enrolled